A single blind, parallel, randomised Phase-III comparative study to evaluate safety and immunogenicity of two intramuscular doses of inactivated Hepatitis A vaccine administered 6 months apart, in 1-15 year-old healthy Hepatitis A vaccine-naive children
Latest Information Update: 22 Nov 2021
At a glance
- Drugs Hepatitis A vaccine (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics; Registrational
- Sponsors Biological E Limited
Most Recent Events
- 08 Nov 2021 Status changed from active, no longer recruiting to completed, results published in the Vaccine.
- 08 Nov 2021 Results published in the Vaccine
- 10 Jan 2020 Status changed from recruiting to active, no longer recruiting.